Participants
Who attends the Convergence Forum?
Pharmaceutical Execs,
CIOs, CTOs, CEOs
Biotech Entrepreneurs,
Start-up Companies
Innovators,
Medical Device Inventors
Life Science Investors,
Bankers, Backers
Academic Researchers,
Analysts, Journalists
You?
When fields converge
What opportunities get created as fields converge? What challenges surface as markets, policies, and investing dynamics shift? What new scientific discoveries are potential game-changers? Convergence exists to explore those questions (and many others), with a high-level audience interested in what’s happening in the rapidly-converging worlds of biotech, pharma, healthcare, medical devices, and the Internet.
The Convergence Forum fosters real debate and discussion among audiences that are every bit as high-level as the speakers. The programs provide an opportunity for participants to make important new contacts, do business, explore important new directions in research, delve deeply into what it takes to maintain competitive advantage in a fast-changing world, and leave feeling recharged.
Companies represented at the 2017 Convergence Forum included:
AbbVie Ventures
Accele Biopharma, Inc.
Agios Pharmaceuticals
Alexandria Real Estate Equities
Alzheimer’s Drug Discovery Foundation
Aquilo Partners
Arrakis Therapeutics
Atlas Venture
Back Bay Life Science Advisors
Baillie Gifford & Co.
Be the Partner, LLC
Bessemer Venture Partners
Biogen
Blue Cross Blue Shield of Massachusetts
Brigham and Women’s Hospital
Broad Institute
CBT Advisors
Centogene AG
Churchill Pharma
Codiak Biosciences
Crispr Therapeutics
Dana-Farber Cancer Institute
Egalet
EMD Serono
Evotec AG
Foley & Lardner
F-Prime Capital Partners
GNS Healthcare
Halloran Consulting Group
Harvard University
Inotek Pharmaceuticals
IRX Therapeutics
ISB
Johnson & Johnson
Jounce Therapeutics
Koch Institute at MIT
Lightstone Ventures
Longitude Capital
LSP
Luc Therapeutics, Inc.
Lumira Capital
Lysosomal Therapeutics
MacDougall Biomedical Communications
Massachusetts Life
Sciences Center
Merck Research Laboratories
MIT
Michael J. Fox Foundation
Microchips Biotech, Inc.
Millendo Therapeutics
Momenta Pharmaceuticals
Navitor Pharmaceuticals
NGM Biopharmaceuticals
Nitto Avecia Inc.
Noveome Biotherapeutics Inc.
Oxford Finance LLC
Park Square Executive Search
Parker Institute for Cancer Immunotherapy
Pfizer, Inc.
Potenza Therapuetics
Red Sky
Resilience Therapeutics
RMG Associates, LLC
Sanofi
Shire
Sobi
Spiral Therapeutics
Stat
Stromasys
Sunovion Pharmaceuticals Inc.
SV Health Investors
Synlogic Therapeutics
Takeda Pharmaceuticals International
Teva Pharmaceuticals
Timmerman Report
TriNetX
Vertex Pharmaceuticals
ViS Research Institute
Wyss Institute
Zafgen Inc.
Request an invite for the next Convergence Forum. Please call 617-437-1400 or email Alyssa Stern at astern@convergenceforum.com for additional information.